Fast Market Research announces the availability of the new TechNavio report, "Global Cervical Cancer Diagnostic Testing Market 2016-2020", on their comprehensive research portal

Boston, MA -- (SBWire) -- 02/16/2017 --The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. This test enables women aged 21 years and above to get screened, making most of the pre-cancerous lesions identifiable at stages when they can be treated easily. In the US, National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides low-cost even free cervical cancer screening for uninsured and low-income women. As per the Affordable Care Act, all health insurance plans initiated after September 23, 2010, should provide recommended cervical cancer screening tests to end-users. In developing countries, with the widespread awareness programs by public organizations like the WHO along with government initiatives, visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) are being performed to screen women. This initiative is expected to raise the market demand for cervical cancer screening and diagnostic tests.

Get More Details on this Report and a Full Table of Contents at Global Cervical Cancer Diagnostic Testing Market 2016-2020

Technavio's analysts forecast the global cervical cancer diagnostic testing market to grow at a CAGR of 6.90% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cervical cancer diagnostic testing market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cervical cancer testing products used to perform cervical cancer screening.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Cervical Cancer Diagnostic Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-Abbott Molecular
-Becton
-Dickinson & Company
-Hologic
-Qiagen
-Quest Diagnostics
-Roche Molecular Diagnostics

Other prominent vendors

-Arbor Vita
-Autogenomics
-bioMerieux
-BioVantra
-Cancer Genetics
-Cepheid
-Cervia Diagnostics
-Cytoimmun
-DAAN Gene
-Delphi Bioscience
-DiaCarta
-Fujirebio
-Genera Biosystems
-Greiner Bio-One
-Guided Therapeutics
-GynaeHealth
-IncellDx
-Micromedic Technologies
-Norchip
-OncoHealth
-OralDNA Labs
-Seegene
-Solopap International
-Trovagene

Market driver

-Increasing global activities by public organizations.
-For a full, detailed list, view our report

Market challenge

-Rising awareness toward cervical cancer over-screening.
-For a full, detailed list, view our report

Market trend

-Development of new diagnostic platforms.
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Abbott Molecular, Becton, Dickinson & Company, Hologic, Qiagen, Quest Diagnostics, Roche Molecular Diagnostics, Arbor Vita, Autogenomics, bioMerieux, BioVantra, Cancer Genetics, Cepheid, Cervia Diagnostics, Cytoimmun, DAAN Gene, Delphi Bioscience, DiaCarta, Fujirebio, Genera Biosystems, Greiner Bio-One, Guided Therapeutics, GynaeHealth, IncellDx, Micromedic Technologies, Norchip, OncoHealth, OralDNA Labs, Seegene, Solopap International, Trovagene

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:
-Global HPV Testing Market 2016-2020
-Global Fecal Occult Testing market 2016-2020
-Global Cancer Diagnostics Device Market 2016-2020
-Life Science Instrumentation Market - Global Forecast to 2021
-Medical and Diagnostic Laboratory Services Global Market Report 2016